Global Atopic Dermatitis Treatment Market 2022-2028

December 2022 | 69 pages | ID: GAC460D6F448EN
Gen Consulting Company

Abstracts

The global atopic dermatitis treatment market is expected to increase by USD 6.2 billion, at a compound annual growth rate (CAGR) of 13.6% from 2022 to 2028, according to the latest edition of the Global Atopic Dermatitis Treatment Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global atopic dermatitis treatment market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the atopic dermatitis treatment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug class, gender, age group, severity, and region. The global market for atopic dermatitis treatment can be segmented by drug class: topical steroid, topical calcineurin inhibitor, others. The topical steroid segment was the largest contributor to the global atopic dermatitis treatment market in 2021. Atopic dermatitis treatment market is further segmented by gender: female, male. According to the research, the male segment had the largest share in the global atopic dermatitis treatment market. Based on age group, the atopic dermatitis treatment market is segmented into: 19 years & above, 18 years & below. The 19 years & above segment held the largest revenue share in 2021. On the basis of severity, the atopic dermatitis treatment market also can be divided into: moderate, mild, severe. Globally, the mild segment made up the largest share of the atopic dermatitis treatment market. Atopic dermatitis treatment market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation

By drug class: topical steroid, topical calcineurin inhibitor, others

By gender: female, male

By age group: 19 years & above, 18 years & below

By severity: moderate, mild, severe

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global atopic dermatitis treatment market is highly concentrated and dominated by only a few companies: LEO Pharma A/S, Novartis AG, Pfizer Inc., Sanofi S.A., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global atopic dermatitis treatment market.
• To classify and forecast the global atopic dermatitis treatment market based on drug class, gender, age group, severity, region.
• To identify drivers and challenges for the global atopic dermatitis treatment market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global atopic dermatitis treatment market.
• To identify and analyze the profile of leading players operating in the global atopic dermatitis treatment market.

Why Choose This Report

• Gain a reliable outlook of the global atopic dermatitis treatment market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG CLASS

Topical steroid
Topical calcineurin inhibitor
Others

PART 6. MARKET BREAKDOWN BY GENDER

Female
Male

PART 7. MARKET BREAKDOWN BY AGE GROUP

19 years & above
18 years & below

PART 8. MARKET BREAKDOWN BY SEVERITY

Moderate
Mild
Severe

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

LEO Pharma A/S
Novartis AG
Pfizer Inc.
Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER